Opportunity
SAM #19AQMM26F1490
Sole-source order for Sanofi Fluzone and Flublok influenza vaccines
Buyer
Bureau of Administration Acquisitions Division
Posted
October 21, 2026
Identifier
19AQMM26F1490
NAICS
325412, 325414
The Department of State’s notice concerns an annual sole-source order for Sanofi influenza vaccines for the 2026–2027 flu season. - Award and value: A $68,964 firm-fixed-price delivery order is described for Sanofi Pasteur under VA Federal Supply Schedule contract 36F79722D0104. - Products: High-dose Fluzone and Flublok influenza vaccines for immunocompromised embassy family members. The notice does not state quantities or part numbers. - Delivery requirements: Vaccines require cold-chain storage and distribution to embassies and consulates before the flu season. - Competition rationale: The justification states that Sanofi is the only manufacturer of the specified proprietary vaccines; the order is planned as a sole-source procurement.
Description
Fluzone and Flublok Influenza Vaccines for the 2026-2027 Flu season. The vaccine is required to immunize embassy immunocompromised family members.